Notice of Upcoming Funding Opportunity: Biomedical Research for HIV/AIDS and STBBI

Introduction

CIHR is pleased to announce the upcoming launch of the Catalyst Grant: Innovative Technologies and Next Generation Interventions for Biomedical Research in HIV/AIDS and STBBI.

Overview

The overall goal of this funding opportunity is to catalyze and strengthen the innovation landscape of HIV/AIDS and STBBI biomedical research in Canada in order to address the most pressing and persistent biomedical challenges to effective treatment of key populations disproportionately affected by STBBI.

Research Areas

The Catalyst Grant funding opportunity will support projects relevant to the following research areas:

• Innovation for next-generation testing and surveillance technology, including, but not limited to, use of digital technology, AI, remote imaging, and wastewater testing;
• Innovation for next-generation therapeutic interventions, including, but not limited to, long-acting anti-virals and anti-bacterials, and novel drugs or approaches for targeting viral reservoirs, or to overcome antimicrobial resistance;
• Innovation for next-generation prevention technologies, including, but not limited to, new vaccine and/or delivery platforms, alternatives to vaccines, and multipurpose prevention technologies.

Applicants will be required to articulate the innovative elements of their proposals that will address a critical gap in the cascade of care.

Funds Available

The total amount available for this funding opportunity is anticipated to be $2,400,000, enough to fund approximately 12 grants.

The maximum amount per grant is anticipated to be $200,000 per year for up to 1 year.

Anticipated Timelines

Launch: July 2024
Application Deadline: October 2024
Funding Start Date: February 2025

The official CIHR funding opportunity will be posted on ResearchNet in the coming weeks.

For a full list of CIHR funding opportunities, please visit ResearchNet.

Contact Information

Date modified:

2024-06-10